ANI PHARMACEUTICALS INC's ticker is and the CUSIP is 00182CAA1. A total of 25 filers reported holding ANI PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $30,000 | -11.8% | 28,000 | 0.0% | 0.00% | – |
| Q2 2019 | $34,000 | +9.7% | 28,000 | 0.0% | 0.00% | – |
| Q1 2019 | $31,000 | +10.7% | 28,000 | 0.0% | 0.00% | – |
| Q4 2018 | $28,000 | -6.7% | 28,000 | 0.0% | 0.00% | – |
| Q3 2018 | $30,000 | -6.2% | 28,000 | 0.0% | 0.00% | – |
| Q2 2018 | $32,000 | +3.2% | 28,000 | 0.0% | 0.00% | – |
| Q1 2018 | $31,000 | +675.0% | 28,000 | +600.0% | 0.00% | – |
| Q2 2017 | $4,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2017 | $4,000 | -86.2% | 4,000 | -84.0% | 0.00% | – |
| Q4 2016 | $29,000 | +480.0% | 25,000 | +525.0% | 0.00% | – |
| Q3 2016 | $5,000 | -54.5% | 4,000 | -60.0% | 0.00% | – |
| Q2 2016 | $11,000 | +22.2% | 10,000 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -78.6% | 10,000 | -76.7% | 0.00% | – |
| Q4 2015 | $42,000 | +600.0% | 43,000 | +616.7% | 0.00% | – |
| Q3 2015 | $6,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CVI Holdings, LLC | 9,000,000 | $10,149,000 | 12.63% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 29,751,000 | $33,847,000 | 2.02% |
| Wellesley Asset Management | 25,925 | $29,366,000 | 1.76% |
| MANGROVE PARTNERS IM, LLC | 18,779 | $21,455,000 | 1.38% |
| Perceptive Advisors | 7,500,000 | $8,458,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,857,000 | $7,767,000 | 0.11% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,975,000 | $6,769,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,718,000 | $1,945,000 | 0.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 930,000 | $1,049,000 | 0.03% |
| GABELLI FUNDS LLC | 1,750,000 | $1,983,000 | 0.01% |